Hyperhomocysteinemia
Condition in which the plasma levels of homocysteine and related metabolites are elevated (>13.9 μmol/l). Hyperhomocysteinemia can be familial or acquired. Development of the acquired hyperhomocysteinemia is mostly associated with vitamins B and/or folate deficiency (e.g., PERNICIOUS ANEMIA, vitamin malabsorption). Familial hyperhomocysteinemia often results in a more severe elevation of total homocysteine and excretion into the urine, resulting in HOMOCYSTINURIA. Hyperhomocysteinemia is a risk factor for cardiovascular and neurodegenerative diseases, osteoporotic fractures and complications during pregnancy.
Subtype terms (1)
More specific conditions that are subtypes of Hyperhomocysteinemia in the MeSH hierarchy.
- Homocystinuria
7 drugs (3 approved, 4 experimental)
Drugs by status
Phase 4 trials (5)
Phase 3 trials (5)
Phase 2 trials (1)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (15)
- Center for Health, Exercise and Sport Sciences, Serbia
- Huazhong University of Science and Technology
- Anhui Medical University
- Harbin Medical University
- Sichuan University
- Xuzhou Medical University
- Capital Medical University
- Fudan University
- Fujian Medical University
- Zhejiang University
- Jiao Tong University
- National Natural Science Foundation of China
- Shantou University
- China Medical University
- People's Liberation Army of China
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (8)